PF-Atlas › Clinical Trials › NCT01214187
Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis
inhaled carbon monoxide · Phase 2
Registry ID
NCT01214187
Phase
Phase 2
Status
Completed
Drug / intervention
inhaled carbon monoxide
Sponsor
Brigham and Women's Hospital
Start
2011-07
Enrollment
58
Locations
8
About this trial
The purpose of this study is to determine whether low concentration inhaled carbon monoxide is effective in treating idiopathic pulmonary fibrosis.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT01214187 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.